Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Non-Current Debt (2016 - 2024)

Historic Non-Current Debt for Prestige Consumer Healthcare (PBH) over the last 16 years, with Q1 2024 value amounting to $1.1 billion.

  • Prestige Consumer Healthcare's Non-Current Debt fell 1634.61% to $1.1 billion in Q1 2024 from the same period last year, while for Mar 2024 it was $1.1 billion, marking a year-over-year decrease of 1634.61%. This contributed to the annual value of $1.1 billion for FY2024, which is 1634.61% down from last year.
  • According to the latest figures from Q1 2024, Prestige Consumer Healthcare's Non-Current Debt is $1.1 billion, which was down 1634.61% from $1.3 billion recorded in Q1 2023.
  • In the past 5 years, Prestige Consumer Healthcare's Non-Current Debt ranged from a high of $1.7 billion in Q1 2020 and a low of $1.1 billion during Q1 2024
  • Its 5-year average for Non-Current Debt is $1.5 billion, with a median of $1.5 billion in 2021.
  • Its Non-Current Debt has fluctuated over the past 5 years, first decreased by 20.24% in 2022, then crashed by 1634.61% in 2024.
  • Prestige Consumer Healthcare's Non-Current Debt (Quarter) stood at $1.5 billion in 2020, then decreased by 0.22% to $1.5 billion in 2021, then decreased by 4.45% to $1.5 billion in 2022, then fell by 8.86% to $1.3 billion in 2023, then decreased by 16.35% to $1.1 billion in 2024.
  • Its Non-Current Debt stands at $1.1 billion for Q1 2024, versus $1.3 billion for Q1 2023 and $1.5 billion for Q1 2022.